￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The supply situation and purchase method of Quizartinib in the Hong Kong market

2026-02-01 22:25:32

Check Details
Has Inavolisib been included in the National Medical Insurance List?

2026-02-01 22:25:32

Check Details
Is Nilotinib a typical targeted therapy drug?

2026-02-01 22:25:32

Check Details
When is Revumenib expected to officially enter the Chinese market?

2026-02-01 22:25:32

Check Details
Is there a generic version of Zenocutuzumab available?

2026-02-01 22:25:32

Check Details
How long does it take to see results after using Cosibelimab?

2026-02-01 22:25:32

Check Details
Which one is more effective, Ensartinib or Aletinib?

2026-02-01 22:25:32

Check Details
Recommended dosage and usage cycle of Datopotamab

2026-02-01 22:25:32

Check Details
What is the difference between the pharmacological mechanisms of Mirdametinib and Selumetinib?

2026-02-01 22:25:32

Check Details
Can Vimseltinib be taken simultaneously with other targeted or chemotherapy drugs?

2026-02-01 22:25:32

Check Details
Atrasentan is expected to be launched in China in a few months of 2025

2026-02-01 22:25:32

Check Details
Summary of matters needing attention when using Telisotuzumab

2026-02-01 22:25:32

Check Details
Category
相关知识